DK2229946T3 - Anvendelse af vækst-stimulerende protein KIAA1524 - Google Patents

Anvendelse af vækst-stimulerende protein KIAA1524

Info

Publication number
DK2229946T3
DK2229946T3 DK10168717.6T DK10168717T DK2229946T3 DK 2229946 T3 DK2229946 T3 DK 2229946T3 DK 10168717 T DK10168717 T DK 10168717T DK 2229946 T3 DK2229946 T3 DK 2229946T3
Authority
DK
Denmark
Prior art keywords
growth
stimulating protein
kiaa1524
preventing
treating
Prior art date
Application number
DK10168717.6T
Other languages
English (en)
Inventor
Pietri Puustinen
Melissa Junttila
Jukka Westermarck
Original Assignee
Turun Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turun Yliopisto filed Critical Turun Yliopisto
Application granted granted Critical
Publication of DK2229946T3 publication Critical patent/DK2229946T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
DK10168717.6T 2006-03-16 2007-03-14 Anvendelse af vækst-stimulerende protein KIAA1524 DK2229946T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20060246A FI20060246A0 (fi) 2006-03-16 2006-03-16 Uusi kasvua stimuloiva proteiini ja sen käyttö
EP07730631A EP2004202B1 (en) 2006-03-16 2007-03-14 Use of a growth-stimulating protein

Publications (1)

Publication Number Publication Date
DK2229946T3 true DK2229946T3 (da) 2013-10-14

Family

ID=36191923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10168717.6T DK2229946T3 (da) 2006-03-16 2007-03-14 Anvendelse af vækst-stimulerende protein KIAA1524

Country Status (11)

Country Link
US (3) US20090232821A1 (da)
EP (2) EP2229946B1 (da)
JP (1) JP5139332B2 (da)
CN (1) CN101443022B (da)
AT (1) ATE485047T1 (da)
CA (1) CA2646898A1 (da)
DE (1) DE602007009950D1 (da)
DK (1) DK2229946T3 (da)
ES (1) ES2429131T3 (da)
FI (1) FI20060246A0 (da)
WO (1) WO2007104835A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20060246A0 (fi) * 2006-03-16 2006-03-16 Jukka Westermarck Uusi kasvua stimuloiva proteiini ja sen käyttö
CA2677207A1 (en) * 2007-02-01 2008-08-07 University Of Florida Research Foundation, Inc. Compositions and methods for detecting cancers in a subject
CN101664550A (zh) * 2008-09-07 2010-03-10 苏州爱生基因有限公司 治疗或预防癌症的方法和药物
FI20115876A0 (fi) 2011-09-06 2011-09-06 Turun Yliopisto Yhdistelmähoito
CN103484463A (zh) * 2013-09-12 2014-01-01 四川大学 一种沉默人c2orf68基因的shRNA及其医药用途
WO2016203118A1 (en) * 2015-06-18 2016-12-22 Turun Yliopisto Crystal structures of cip2a
DK3714070T3 (da) 2017-11-20 2022-02-07 Turun Yliopisto Hidtil ukendt cip2a-variant og anvendelser deraf
CN111549033B (zh) * 2020-06-11 2021-02-12 南京市江宁医院 慢病毒感染人表皮角质细胞株及其构建方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026394A1 (en) 2000-02-11 2007-02-01 Lawrence Blatt Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies
KR20080023768A (ko) * 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체
US20030190635A1 (en) 2002-02-20 2003-10-09 Mcswiggen James A. RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
CZ302719B6 (cs) * 2000-12-01 2011-09-21 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Izolovaná molekula dvouretezcové RNA, zpusob její výroby a její použití
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
US20030175950A1 (en) 2001-05-29 2003-09-18 Mcswiggen James A. RNA interference mediated inhibition of HIV gene expression using short interfering RNA
US20040019001A1 (en) 2002-02-20 2004-01-29 Mcswiggen James A. RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
WO2004028471A2 (en) 2002-09-28 2004-04-08 Massachusetts Institute Of Technology Influenza therapeutic
ATE517992T1 (de) * 2002-11-14 2011-08-15 Dharmacon Inc Funktionelle und hyperfunktionelle sirna
EP2003196A3 (en) * 2003-06-09 2009-01-07 The Regents of the University of Michigan Compositions and methods for treating and diagnosing cancer
US20050043266A1 (en) 2003-07-25 2005-02-24 Sumedha Jayasena Short interfering RNA as an antiviral agent for hepatitis C
EP1752536A4 (en) * 2004-05-11 2008-04-16 Alphagen Co Ltd POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME
FI20060246A0 (fi) * 2006-03-16 2006-03-16 Jukka Westermarck Uusi kasvua stimuloiva proteiini ja sen käyttö

Also Published As

Publication number Publication date
EP2004202A4 (en) 2009-11-11
EP2229946A3 (en) 2011-01-19
EP2004202A1 (en) 2008-12-24
JP2009530593A (ja) 2009-08-27
DE602007009950D1 (de) 2010-12-02
WO2007104835A1 (en) 2007-09-20
ATE485047T1 (de) 2010-11-15
US9062309B2 (en) 2015-06-23
ES2429131T3 (es) 2013-11-13
US20090232821A1 (en) 2009-09-17
CA2646898A1 (en) 2007-09-20
EP2229946A2 (en) 2010-09-22
US20120077750A1 (en) 2012-03-29
EP2229946B1 (en) 2013-08-14
CN101443022A (zh) 2009-05-27
CN101443022B (zh) 2012-05-30
JP5139332B2 (ja) 2013-02-06
US8410072B2 (en) 2013-04-02
EP2004202B1 (en) 2010-10-20
US20130197063A1 (en) 2013-08-01
FI20060246A0 (fi) 2006-03-16

Similar Documents

Publication Publication Date Title
DK2229946T3 (da) Anvendelse af vækst-stimulerende protein KIAA1524
DE602005012993D1 (de) Einheit zur behandlung von pellets
BRPI0513310A (pt) análogos de tetrapeptìdeo
ECSP088118A (es) Sales de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
CL2008003395A1 (es) Compuestos derivados de 1h-2-tia-1,5,8-triaza-naftaleno 2,2-dioxido; compuestos intermediarios; metodo para controlar plantas; y composicion herbicida que comprende a dichos compuestos.
ATE530210T1 (de) Endoprothesen
BRPI0715763A2 (pt) tratamento ou prevenÇço de cÂnceres superexpressando reg4 ou kiaa0101
DE502005011119D1 (da)
EA201992262A1 (ru) Композиции и способы контроля нематод
ECSP088369A (es) Novedosos derivados de 1-aza-bicicloalquilo para el tratamiento de trastornos psicóticos y neurodegenerativos
EA200900327A1 (ru) Способ борьбы с патогенами растений
DK1962604T3 (da) Plantevækstregulerende sammensætninger
ATE538095T1 (de) Verfahren zur herstellung von 2-substituierten 5- (1-alkylthio)-alkylpyridinen
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA201100874A1 (ru) Соединения для лечения рака
ATE420075T1 (de) Neue heterocyclylethylbenzamidderivate
TW200716132A (en) Novel chemical compounds
ATE443991T1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
DE602006021626D1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon-derivate zur verwendung als h3-modulatoren
PL1865766T3 (pl) Gniazda dla niosek
EA200801296A1 (ru) Способ лечения метаболического синдрома
DE50312430D1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
ATE425269T1 (de) Zusammensetzung zur behandlung von leder
TW200716579A (en) Novel chemical compounds
ATE458507T1 (de) Implantat mit mehrfachbeschichtung